alendronate has been researched along with Back Pain in 17 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
Back Pain: Acute or chronic pain located in the posterior regions of the THORAX; LUMBOSACRAL REGION; or the adjacent regions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The purpose of this study was to investigate the effect of alendronate on metacarpal and lumbar bone mineral density (BMD), bone resorption, and chronic back pain in postmenopausal women with osteoporosis." | 9.11 | Effects of alendronate on metacarpal and lumbar bone mineral density, bone resorption, and chronic back pain in postmenopausal women with osteoporosis. ( Iwamoto, J; Sato, Y; Takeda, T; Uzawa, M, 2004) |
| "Exercise may enhance the effect of alendronate on bone mineral density (BMD) and reduce chronic back pain in elderly women with osteoporosis." | 9.11 | Effect of whole-body vibration exercise on lumbar bone mineral density, bone turnover, and chronic back pain in post-menopausal osteoporotic women treated with alendronate. ( Iwamoto, J; Sato, Y; Takeda, T; Uzawa, M, 2005) |
| "To compare the effects on back pain of teriparatide versus alendronate, we analyzed the reporting of back pain in a head to head comparator trial and a followup study." | 9.11 | Longterm reduction of back pain risk in women with osteoporosis treated with teriparatide compared with alendronate. ( Body, JJ; Chen, P; Krege, JH; Miller, PD; Rohe, ME; Shergy, WJ, 2005) |
| "The purpose of the present study was to compare the effects of treatment with etidronate and alendronate on bone resorption, back pain, and activities of daily living (ADL) in elderly women with vertebral fractures." | 9.10 | Comparative effects of treatment with etidronate and alendronate on bone resorption, back pain, and activities of daily living in elderly women with vertebral fractures. ( Ichimura, S; Iwamoto, J; Takeda, T; Uzawa, M, 2003) |
| "To determine the effect of alendronate therapy on days affected by back pain in postmenopausal women with existing vertebral fractures." | 9.09 | Effect of alendronate on limited-activity days and bed-disability days caused by back pain in postmenopausal women with existing vertebral fractures. Fracture Intervention Trial Research Group. ( Black, DM; Cummings, SR; Ensrud, K; Nevitt, MC; Rubin, SR; Thompson, DE; Yates, AJ, 2000) |
| "Efficacy and safety of a new combination package containing 4 or 12 self-explanatory one-week blisters, each with one tablet of 70 mg alendronate (CAS 260055-05-8) and 7 capsules of 1 microg alfacalcidol (CAS 41294-56-8) (Tevabone) on muscle power, muscle function, balance and back pain was investigated in an open, multi-centered, uncontrolled, prospective study on a cohort of elderly patients with a high risk of falls and fractures." | 7.77 | Risk reduction of falls and fractures, reduction of back pain and safety in elderly high risk patients receiving combined therapy with alfacalcidol and alendronate: a prospective study. ( Ringe, JD; Schacht, E, 2011) |
| "The purpose of this study was to investigate the effect of alendronate on metacarpal and lumbar bone mineral density (BMD), bone resorption, and chronic back pain in postmenopausal women with osteoporosis." | 5.11 | Effects of alendronate on metacarpal and lumbar bone mineral density, bone resorption, and chronic back pain in postmenopausal women with osteoporosis. ( Iwamoto, J; Sato, Y; Takeda, T; Uzawa, M, 2004) |
| "Exercise may enhance the effect of alendronate on bone mineral density (BMD) and reduce chronic back pain in elderly women with osteoporosis." | 5.11 | Effect of whole-body vibration exercise on lumbar bone mineral density, bone turnover, and chronic back pain in post-menopausal osteoporotic women treated with alendronate. ( Iwamoto, J; Sato, Y; Takeda, T; Uzawa, M, 2005) |
| "To compare the effects on back pain of teriparatide versus alendronate, we analyzed the reporting of back pain in a head to head comparator trial and a followup study." | 5.11 | Longterm reduction of back pain risk in women with osteoporosis treated with teriparatide compared with alendronate. ( Body, JJ; Chen, P; Krege, JH; Miller, PD; Rohe, ME; Shergy, WJ, 2005) |
| "The purpose of this open-labeled prospective study was to compare the treatment effects of cyclical etidronate and alendronate on the lumbar bone mineral density (BMD), bone resorption, and back pain in elderly women with osteoporosis." | 5.11 | Comparison of effect of treatment with etidronate and alendronate on lumbar bone mineral density in elderly women with osteoporosis. ( Iwamoto, J; Sato, Y; Takeda, T; Uzawa, M, 2005) |
| "The purpose of the present study was to examine the early response of lumbar bone mineral density (BMD), bone resorption, and back pain to alendronate after treatment with cyclical etidronate in postmenopausal women with osteoporosis." | 5.10 | Early response to alendronate after treatment with etidronate in postmenopausal women with osteoporosis. ( Ichimura, S; Iwamoto, J; Takeda, T; Uzawa, M, 2003) |
| "The purpose of the present study was to compare the effects of treatment with etidronate and alendronate on bone resorption, back pain, and activities of daily living (ADL) in elderly women with vertebral fractures." | 5.10 | Comparative effects of treatment with etidronate and alendronate on bone resorption, back pain, and activities of daily living in elderly women with vertebral fractures. ( Ichimura, S; Iwamoto, J; Takeda, T; Uzawa, M, 2003) |
| "To determine the effect of alendronate therapy on days affected by back pain in postmenopausal women with existing vertebral fractures." | 5.09 | Effect of alendronate on limited-activity days and bed-disability days caused by back pain in postmenopausal women with existing vertebral fractures. Fracture Intervention Trial Research Group. ( Black, DM; Cummings, SR; Ensrud, K; Nevitt, MC; Rubin, SR; Thompson, DE; Yates, AJ, 2000) |
| "Efficacy and safety of a new combination package containing 4 or 12 self-explanatory one-week blisters, each with one tablet of 70 mg alendronate (CAS 260055-05-8) and 7 capsules of 1 microg alfacalcidol (CAS 41294-56-8) (Tevabone) on muscle power, muscle function, balance and back pain was investigated in an open, multi-centered, uncontrolled, prospective study on a cohort of elderly patients with a high risk of falls and fractures." | 3.77 | Risk reduction of falls and fractures, reduction of back pain and safety in elderly high risk patients receiving combined therapy with alfacalcidol and alendronate: a prospective study. ( Ringe, JD; Schacht, E, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 12 (70.59) | 29.6817 |
| 2010's | 5 (29.41) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ofluoglu, O | 1 |
| Ofluoglu, D | 1 |
| Iwamoto, J | 6 |
| Makita, K | 1 |
| Sato, Y | 4 |
| Takeda, T | 6 |
| Matsumoto, H | 1 |
| Schacht, E | 2 |
| Ringe, JD | 2 |
| Dukas, L | 1 |
| Mazor, Z | 1 |
| Dytfeld, J | 1 |
| Horst-Sikorska, W | 1 |
| Yoshioka, T | 1 |
| Okimoto, N | 1 |
| Okamoto, K | 1 |
| Sakai, A | 1 |
| Ichimura, S | 2 |
| Uzawa, M | 5 |
| Witzig, M | 1 |
| Bützberger, S | 1 |
| Caravatti, M | 1 |
| Furrer, J | 1 |
| Schulthess, G | 1 |
| Sarikaya, S | 1 |
| Ozdolap, S | 1 |
| Açikgöz, G | 1 |
| Erdem, CZ | 1 |
| Nakamura, T | 1 |
| Ghose, R | 1 |
| Miller, PD | 1 |
| Shergy, WJ | 1 |
| Body, JJ | 1 |
| Chen, P | 1 |
| Rohe, ME | 1 |
| Krege, JH | 1 |
| Nevitt, MC | 1 |
| Thompson, DE | 1 |
| Black, DM | 1 |
| Rubin, SR | 1 |
| Ensrud, K | 1 |
| Yates, AJ | 1 |
| Cummings, SR | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy and Safety of Minodronate in the Treatment of Postmenopausal Osteoporosis With Low Back Pain: a Single-centre and Randomized Controlled Trial[NCT05645289] | Phase 4 | 72 participants (Anticipated) | Interventional | 2023-01-01 | Not yet recruiting | ||
| A 5-year, Double-blind, Randomized, Placebo-controlled Extension Study to Examine the Long-term Safety and Efficacy of Oral Alendronate in Postmenopausal Women Who Previously Received Alendronate in Conjunction With the Fracture Intervention Trial[NCT00398931] | Phase 3 | 1,099 participants (Actual) | Interventional | 1998-02-28 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for alendronate and Back Pain
| Article | Year |
|---|---|
[Fracture Intervention Trial I and II(alendronate)].
Topics: Activities of Daily Living; Alendronate; Back Pain; Controlled Clinical Trials as Topic; Humans; Ost | 2004 |
9 trials available for alendronate and Back Pain
| Article | Year |
|---|---|
Alendronate is more effective than elcatonin in improving pain and quality of life in postmenopausal women with osteoporosis.
Topics: Aged; Aged, 80 and over; Alendronate; Alkaline Phosphatase; Back Pain; Calcitonin; Collagen Type I; | 2011 |
A comparative study of the effects of daily minodronate and weekly alendronate on upper gastrointestinal symptoms, bone resorption, and back pain in postmenopausal osteoporosis patients.
Topics: Aged; Alendronate; Back Pain; Biomarkers; Bone Density; Bone Density Conservation Agents; Bone Remod | 2013 |
Early response to alendronate after treatment with etidronate in postmenopausal women with osteoporosis.
Topics: Aged; Aged, 80 and over; Alendronate; Back Pain; Bone Density; Calcium; Collagen; Collagen Type I; E | 2003 |
Comparative effects of treatment with etidronate and alendronate on bone resorption, back pain, and activities of daily living in elderly women with vertebral fractures.
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Alendronate; Back Pain; Bone Resorption; Disabi | 2003 |
Effects of alendronate on metacarpal and lumbar bone mineral density, bone resorption, and chronic back pain in postmenopausal women with osteoporosis.
Topics: Absorptiometry, Photon; Aged; Aged, 80 and over; Alendronate; Back Pain; Biomarkers; Bone Density; B | 2004 |
Effect of whole-body vibration exercise on lumbar bone mineral density, bone turnover, and chronic back pain in post-menopausal osteoporotic women treated with alendronate.
Topics: Accidental Falls; Aged; Aged, 80 and over; Alendronate; Alkaline Phosphatase; Back Pain; Bone Densit | 2005 |
Longterm reduction of back pain risk in women with osteoporosis treated with teriparatide compared with alendronate.
Topics: Aged; Alendronate; Back Pain; Female; Follow-Up Studies; Humans; Incidence; Middle Aged; Osteoporosi | 2005 |
Comparison of effect of treatment with etidronate and alendronate on lumbar bone mineral density in elderly women with osteoporosis.
Topics: Aged; Aged, 80 and over; Alendronate; Back Pain; Biomarkers; Bone Density; Bone Density Conservation | 2005 |
Effect of alendronate on limited-activity days and bed-disability days caused by back pain in postmenopausal women with existing vertebral fractures. Fracture Intervention Trial Research Group.
Topics: Activities of Daily Living; Aged; Alendronate; Back Pain; Bed Rest; Bone Density; Double-Blind Metho | 2000 |
7 other studies available for alendronate and Back Pain
| Article | Year |
|---|---|
A case report: pregnancy-induced severe osteoporosis with eight vertebral fractures.
Topics: Adult; Alendronate; Back Pain; Bone Density; Bone Density Conservation Agents; Female; Fractures, Sp | 2008 |
Risk reduction of falls and fractures, reduction of back pain and safety in elderly high risk patients receiving combined therapy with alfacalcidol and alendronate: a prospective study.
Topics: Accidental Falls; Aged; Aged, 80 and over; Alendronate; Back Pain; Bone Density Conservation Agents; | 2011 |
Potency of a combined alfacalcidol-alendronate therapy to reduce the risk of falls and fractures in elderly patients with glucocorticoid-induced osteoporosis.
Topics: Absorptiometry, Photon; Accidental Falls; Aged; Alendronate; Back Pain; Bone Density; Bone Density C | 2011 |
Pregnancy associated osteoporosis--a case report.
Topics: Adult; Alendronate; Back Pain; Bone Density; Bone Density Conservation Agents; Calcium, Dietary; Fem | 2012 |
[Backache and palmar eczema (SAPHO syndrome)].
Topics: Acquired Hyperostosis Syndrome; Alendronate; Anti-Inflammatory Agents, Non-Steroidal; Back Pain; Dia | 2003 |
Pregnancy-associated osteoporosis with vertebral fractures and scoliosis.
Topics: Absorptiometry, Photon; Adult; Alendronate; Back Pain; Bone Density; Calcium Carbonate; Exercise The | 2004 |
Osteomalacia: recovery of bone density.
Topics: 25-Hydroxyvitamin D 2; Absorptiometry, Photon; Aged; Alendronate; Alkaline Phosphatase; Back Pain; B | 2004 |